These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31142816)

  • 1. Molecular degree of perturbation of plasma inflammatory markers associated with tuberculosis reveals distinct disease profiles between Indian and Chinese populations.
    Oliveira-de-Souza D; Vinhaes CL; Arriaga MB; Kumar NP; Cubillos-Angulo JM; Shi R; Wei W; Yuan X; Zhang G; Cai Y; Barry CE; Via LE; Sher A; Babu S; Mayer-Barber KD; Nakaya HI; Fukutani KF; Andrade BB
    Sci Rep; 2019 May; 9(1):8002. PubMed ID: 31142816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.
    Vinhaes CL; Oliveira-de-Souza D; Silveira-Mattos PS; Nogueira B; Shi R; Wei W; Yuan X; Zhang G; Cai Y; Barry CE; Via LE; Fukutani KF; Andrade BB; Mayer-Barber KD
    Cytokine; 2019 Nov; 123():154759. PubMed ID: 31226436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.
    Belay M; Legesse M; Mihret A; Bekele Y; Ottenhoff TH; Franken KL; Bjune G; Abebe F
    PLoS One; 2015; 10(4):e0124134. PubMed ID: 25897840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis.
    Oliveira-de-Souza D; Vinhaes CL; Arriaga MB; Kumar NP; Queiroz ATL; Fukutani KF; Babu S; Andrade BB
    Sci Rep; 2020 Jul; 10(1):11358. PubMed ID: 32647178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease.
    Andrade BB; Pavan Kumar N; Mayer-Barber KD; Barber DL; Sridhar R; Rekha VV; Jawahar MS; Nutman TB; Sher A; Babu S
    PLoS One; 2013; 8(5):e62618. PubMed ID: 23671613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays.
    Xiong W; Dong H; Wang J; Zou X; Wen Q; Luo W; Liu S; He J; Cai S; Ma L
    PLoS One; 2016; 11(2):e0148885. PubMed ID: 26881918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
    Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment.
    Moideen K; Kumar NP; Bethunaickan R; Banurekha VV; Nair D; Babu S
    Cytokine; 2020 Mar; 127():154929. PubMed ID: 31811994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of tumor necrosis factor-alpha, interferon-gamma, inducible nitric oxide synthase, and 3-nitrotyrosine in drug-resistant and drug-sensitive pulmonary tuberculosis patients, Ibadan, Nigeria.
    Bolajoko EB; Arinola OG; Odaibo GN; Maiga M
    Int J Mycobacteriol; 2020; 9(2):185-189. PubMed ID: 32474541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection.
    Pathakumari B; Anbarasu D; Parthasarathy RT; Raja A
    Tuberculosis (Edinb); 2015 Dec; 95(6):736-743. PubMed ID: 26546406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoarabinomannan-specific TNF-α and IFN-γ as markers of protective immunity against tuberculosis: a cohort study in an endemic setting.
    Belay M; Legesse M; Mihret A; Bekele Y; Bjune G; Abebe F
    APMIS; 2015 Oct; 123(10):851-7. PubMed ID: 26200933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Existing blood transcriptional classifiers accurately discriminate active tuberculosis from latent infection in individuals from south India.
    Leong S; Zhao Y; Joseph NM; Hochberg NS; Sarkar S; Pleskunas J; Hom D; Lakshminarayanan S; Horsburgh CR; Roy G; Ellner JJ; Johnson WE; Salgame P
    Tuberculosis (Edinb); 2018 Mar; 109():41-51. PubMed ID: 29559120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron homeostasis and progression to pulmonary tuberculosis disease among household contacts.
    Minchella PA; Donkor S; McDermid JM; Sutherland JS
    Tuberculosis (Edinb); 2015 May; 95(3):288-93. PubMed ID: 25764944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection.
    Xiao JN; Xiong Y; Chen Y; Xiao YJ; Ji P; Li Y; Wang SJ; Zhao GP; Cheng QJ; Lu SH; Wang Y
    Front Cell Infect Microbiol; 2017; 7():495. PubMed ID: 29250493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined determination of spontaneous and antigen-induced production of cytokines for differential diagnostics of active tuberculosis of lungs and latent tuberculosis infection].
    Vasil'eva EV; Verbov VN; Ivanovskiĭ VB; Zhemkova MF; Nikitina IIu; Liadova IV; Tatolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (4):77-85. PubMed ID: 24341221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.